Hidradenitis suppurativa

Journal of the European Academy of Dermatology and Venereology

Volumn 23, Issue 9, 2009, Pages 985-998

  Revuz, J ^a  

^a NONE   (France)

Author keywords

Acne inversa; Follicular diseases; Hidradenitis suppurativa; Treatment

Indexed keywords

ADALIMUMAB; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIANDROGEN; CEPHALOSPORIN; CLINDAMYCIN; CYPROTERONE ACETATE; DAPSONE; ESTROGEN; ETANERCEPT; GLUCONATE ZINC; INFLIXIMAB; ISOPENICILLIN N; ISOTRETINOIN; METRONIDAZOLE; RETINOID; RIFAMPICIN; STEROID; TETRACYCLINE; TRIAMCINOLONE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; ZINC DERIVATIVE;

ACNE; ANTIBIOTIC THERAPY; APOCRINE GLAND; ARTHROPATHY; CARCINOMA; CLINICAL ASSESSMENT; CLINICAL FEATURE; CROHN DISEASE; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DRUG MEGADOSE; EXCISION; FAMILY HISTORY; FURUNCULOSIS; HIDRADENTIS SUPPURATIVA; HISTOPATHOLOGY; HUMAN; INCISION; LYMPHATIC SYSTEM DISEASE; LYMPHEDEMA; MAINTENANCE THERAPY; MALAISE; OBESITY; PRIORITY JOURNAL; QUALITY OF LIFE; RECURRENT DISEASE; REVIEW; RISK FACTOR; SKIN ABSCESS; SKIN APPENDAGE DISEASE; SKIN INFECTION; SKIN NODULE; SKIN PAIN; SMOKING; SQUAMOUS CELL CARCINOMA; SUPPURATION; SURGICAL DRAINAGE;

ANTI-BACTERIAL AGENTS; DIAGNOSIS, DIFFERENTIAL; HIDRADENITIS SUPPURATIVA; HUMANS; LASER THERAPY; QUALITY OF LIFE; RADIOTHERAPY; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SKIN; STEROIDS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 68749098680     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2009.03356.x     Document Type: Review

References (84)

1. Verneuil A. Etudes sur les tumeurs de la peau; de quelques maladies des glandes sudoripares Archives générales de médecine 1854 t. 4 : 447 468.
2. Shelley WB, Cahn MM. The pathogenesis of hidradenitis suppurativa in man. Arch Dermatol 1955 72 : 562 565.
3. Yu CCW, Cook MG. Hidradenitis suppurativa: a disease of follicular epithelium, rather than apocrine glands. Br J Dermatol 1990 122 : 763 769.
4. Plewig G, Kligman AM. Acne, Morphogenesis and Treatment. Springer, Berlin, 1975 : 192 193.
5. Hidradenitis suppurativa foundation 7895 via Belfiore num;, San Diego, California 92129, http://www.hs.foundation.org.
6. Naldi L. Epidemiology In : Jemec G, Revuz J, Leyden J, eds. Hidradenitis suppurativa Vol. 1, Springer, 2006, pp. 58 64.
7. Revuz JE, Canoui-Poitrine F, Wolkenstein P et al. Prevalence and factors associated with hidradenitis suppurativa: results from two case-control. J Am Acad Dermatol 2008 59 : 596 601.
8. Jemec GB. The symptomatology of hidradenitis suppurativa in women. Br J Dermatol 1988 119 : 345 350.
9. Jemec GB, Heidenheim M, Nielsen NH. The prevalence of hidradenitis suppurativa and its potential precursor lesions. J Am Acad Dermatol 1996 35 : 191 194.
10. Morgan WP, Leicester G. The role of depilation and deodorants in hidradenitis suppurativa. Arch Dermatol 1982 118 : 101 102.
11. Poli F, Jemec GB, Revuz J. Clinical presentation. In : Jemec GBE, Revuz J, Leyden J, eds. Hidradenitis Suppurativa. Springer, Heidelberg, 2006 : 11 24.
12. von der Werth JM, Williams HC. The natural history of hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2000 14 : 389 392.
13. Canoui-Poitrine F, Revuz J, Wolkenstein P et al. Clinical characteristics of a series of 302 French patients suffering from hidradenitis suppurativa, with an analysis of factors associated with disease severity. J Am Acad Dermatol 2009 61 : 51 57.
14. Hurley HJ. Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa, and familial benign pemphigus: surgical approach. In : Roenigk RK, Roenigk HH, eds. Dermatologic Surgery. Marcel Dekker, New York. 1989 : 729 739.
15. von der Werth JM, Jemec GB. Morbidity in patients with hidradenitis suppurativa. Br J Dermatol 2001 144 : 809 813.
16. Wolkenstein P, Loundou A, Barrau K, Auquier P, Revuz J. Quality of life impairment in hidradenitis suppurativa. A study of 61 cases. J Am Acad Dermatol 2007 56 : 621 623.
17. Jemec GB, Heidenheim M, Nielsen NH. Hidradenitis suppurativa - characteristics and consequences. Clin Exp Dermatol 1996 21 : 419 423.
18. Faye O, Petit F, Poli F et al. Lymphedema as a complication of hidradenitis suppurativa in three patients]. Ann Dermatol Venereol 2007 134 : 567 569.
19. Maalouf E, Faye O, Poli F, Cosnes A, Revuz J. Fatal epidermoid carcinoma in hidradenitis suppurativa following treatment with infliximab. Ann Dermatol Venereol 2006 133 : 473 474.
20. Lapins J, Ye W, Nyren O, Emtestam L. Incidence of cancer among patients with hidradenitis suppurativa. Arch Dermatol 2001 137 : 730 734.
21. Jemec GB, Gniadecka M. Sebum excretion in hidradenitis suppurativa. Dermatology 1997 194 : 325 328.
22. Bedlow AJ, Mortimer PS. Dowling-Degos disease associated with hidradenitis suppurativa. Clin Exp Dermatol 1996 21 : 305 306.
23. Seksik P, Contou JF, Cosnes A, Cosnes J. Hidradenitis suppurativa and Crohn's disease. In : Jemec G, Revuz J, Leyden J, eds Hidradenitis suppurativa ' Vol. 1, Springer, 50 57.
24. Church JM, Fazio VW, Lavery IC, Oakley JR, Milsom JW. The differential diagnosis and comorbidity of hidradenitis suppurativa and perianal Crohn's disease. Int J Colorectal Dis 1993 8 : 117 119.
25. Cario E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 2000 68 : 7010 7017.
26. Kurzen H, Kurokawa I, Jemec GBE et al. What causes hidradenitis suppurativa? Exp Dermatol 2008 17 : 455 472.
27. Sellheyer K, Krahl D. Hidradenitis suppurativa is acne inversa! An appeal to finally abandon a misnomer. Int J Dermatol 2005 44 : 535.
28. Jemec GB, Thomsen BM, Hansen U. The homogeneity of hidradenitis suppurativa lesions. A histological study of intra-individual variation. APMIS 1997 105 : 378 383.
29. Jemec GB, Hansen U. Histology of hidradenitis suppurativa. J Am Acad Dermatol 1996 34 : 994 999.
30. Kurokawa I, Nishijima S, Kusumoto K. Immunohistochemical study of cytokeratins in hidradenitis suppurativa (acne inversa). J Int Med Res 2002 30 : 131 136.
31. Jemec GBE, Gniadecka M. Ultrasound examination of hair follicles in hidradenitis. Arch Dermatol 1997 133 : 967 972.
32. Kelly AM, Cronin P. MRI features of hidradenitis suppurativa and review of the literature. AJR Am J Roentgenol 2005 185 : 1201 1204.
33. Von der Werth J, Wood P, Irvine AD, Irwin Mclean WH, Genetics of hidradenitis suppurativa. In : Jemec G, Revuz J, Leyden J, eds Hidradenitis suppurativa ' Vol. 1, Springer, 70 83.
34. Von der Werth JM, Williams HC, Raeburn JA. The clinical genetics of hidradenitis suppurativa revisited. Br J Dermatol 2000 142 : 947 953.
35. Gao M, Wang PG, Cui Y et al. Inversa acne (hidradenitis suppurativa): a case report and identification of the locus at chromosome 1p21.1-1q25.3. J Invest Dermatol 2006 126 : 1302 1306.
36. Nassar D, Hugot JP, Wolkenstein P, Revuz J. Lack of association between CARD15 gene polymorphisms and hidradenitis suppurativa: a pilot study. Dermatology 2007 215 : 359.
37. Lapins J, Olerup O, Emtestam L. No human leukocyte antigen-A, -B or -DR association in Swedish patients with hidradenitis suppurativa. Acta Derm Venereol 2001 81 : 28 30.
38. Oprica C, Nord CE. Bacteriology of hidradenitis suppurativa In : Jemec G, Revuz J, Leyden J eds Hidradenitis suppurativa ' Vol. 1, Springer, pp. 86 93.
39. Wortsman X, Revuz J, Jemec GBE. Lymph nodes in hidradenitis suppurativa - a clue to the aetiology of the disease? Dermatology 2009 219 : 22 24.
40. Harrison BJ, Kumar S, Read GF et al. Hidradenitis suppurativa: evidence for an endocrine abnormality. Br J Surg 1985 72 : 1002 1004.
41. Barth JH, Kealey T. Androgen metabolism by isolated human axillary apocrine glands in hidradenitis suppurativa. Br J Dermatol 1991 125 : 304 308.
42. Giamarellos-Bourboulis EJ, Antonopoulou A, Petropoulou C et al. Altered innate and adaptive immune responses in patients with hidradenitis suppurativa. Br J Dermatol 2007 156 : 51 56.
43. Hunger RE, Surovy AM, Hassan AS, Braathen LR, Yawalkar N. Toll-like receptor 2 is highly expressed in lesions of acne inversa and colocalizes with C-type lectin receptor. Br J Dermatol 2008 158 : 691 697.
44. Gupta AK, Knowles SR, Gupta MA et al. Lithium therapy associated with hidradenitis suppurativa: case report and a review of the dermatologic side effects of lithium. J Am Acad Dermatol 1995 32 : 382 386.
45. Mahe E, Morelson E, Lechaton S et al. Cutaneous adverse events in renal transplant recipients receiving sirolimus-based therapy. Transplantation 2005 79 : 476 482.
46. Sartorius K, Lapins J, Emtestam L, Jemec GB. Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa. Br J Dermatol 2003 149 : 211 213.
47. Revuz J. Modifications et mode d'emploi du score de Sartorius pour évaluer la gravité de l'hidradénite suppurée. Ann Dermatol Venereol 2007 134 : 173 180.
48. Grob JJ, Revuz J, Ortonne JP, Auquier P, Lorette G. Comparative study of the impact of chronic urticaria, psoriasis and atopic dermatitis on the quality of life. Br J Dermatol 2005 152 : 289 295.
49. Revuz J. Place de la chirurgie dans le traitement de l'hidradénite suppurée. Annales de dermatologie et de vénéré ologie 2008 135 : 349 350.
50. Clemmensen OJ. Topical treatment of hidradenitis suppurativa with clindamycin. Int J Dermatol 1983 22 : 325 328.
51. Jemec GB, Wendelboe P. Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa. J Am Acad Dermatol 1998 39 : 971 974.
52. Sartorius K, Boer J, Jemec GBE. Topical treatment. In : Jemec G, Revuz J. Leyden J, eds Hidradenitis suppurativa ' Vol. 1, Springer, 150 160.
53. Fearfield LA, Staughton RC. Severe vulval apocrin acne successfully treated with prednisolone and isotretinoin. Clin Exp Dermatol. 1999 24 : 189 192.
54. Petit F. personnal communication.
55. Gener G, Canoui-Poitrine F, Revuz J, et al. Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients. Dermatology 2009 in press.
56. Mendonça CO, Griffiths CE. Clindamycin and rifampicin combination therapy for hidradenitis suppurativa. Br J Dermatol 2006 154 : 977 978.
57. Hessel H, van der Zee, Boer J, Prens EP, Jemec GBE. The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa. Dermatology 2009 in press.
58. Brocard A, Knol AC, Khammari A, Dréno B. Hidradenitis suppurativa and zinc: a new therapeutic approach. A pilot study. Dermatology 2007 214 : 325 327.
59. Mortimer PS, Dawber RPR, Gales MA, Moore RA. A double-blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa. Br J Dermatol 1986 115 : 263 268.
60. Kraft JN, Searles GE. Hidradenitis suppurativa in 64 female patients: retrospective study comparing oral antibiotics and antiandrogen therapy. J Cutan Med Surg 2007 11 : 125 131.
61. Joseph MA, Jayaseelan E, Ganapathi B, Stephen J. Hidradenitis suppurativa treated with finasteride. J Dermatolog Treat 2005 16 : 75 78.
62. Farrell AM, Randall VA, Vafaee T, Dawber RP. Finasteride as a therapy for hidradenitis suppurativa. Br J Dermatol 1999 141 : 1138 1139.
63. Boer J, van Gemert MJ. Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa. J Am Acad Dermatol 1999 40 : 73 76.
64. Soria A, Canoui-Poitrine F, Wolkenstein P et al. Absence of efficacy of oral isotretinoin in hidradenitis suppurativa: a retrospective study based on patients' outcome assessment. Dermatology 2009 218 : 134 135.
65. Boer J. Oral retinoids for hidradenitis suppurativa. In : Jemec G, Revuz J, Leyden J, eds Hidradenitis suppurativa ' Vol. 1, Springer, 150 160.
66. Kaur MR, Lewis HM. Hidradenitis suppurativa treated with dapsone: a case series of five patients. J Dermatolog Treat 2006 17 : 211 213.
67. Sullivan TP, Welsh E, Kerdel FA, Burdick AE, Kirsner RS. Infliximab for hidradenitis suppurativa. Br J Dermatol 2003 149 : 1046 1049.
68. Cusack C, Buckley C. Etanercept: effective in the management of hidradenitis suppurativa. Br J Dermatol 2006 154 : 726 729.
69. Giamarellos-Bourboulis EJ, Pelekanou E, Antonopoulou A et al. An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa. Br J Dermatol 2008 158 : 567 572.
70. Yamauchi PS, Mau N. Hidradenitis suppurativa managed with adalimumab. J Drugs Dermatol 2009 8 : 181 183.
71. Thielen A-M, Barde C, Saurat Jh. Long-term infliximab for severe hidradenitis suppurativa. Br J Dermatol 2006 155 : 1105 1107.
72. Mekkes JR, Bos JD. Long-term efficacy of a single course of infliximab in hidradenitis suppurativa. Br J Dermatol 2008 158 : 370 374.
73. Zangrilli A, Esposito M, Mio G, Mazzotta A, Chimenti S. Long-term efficacy of etanercept in hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2008 22 : 1260 1262.
74. Fardet L, Dupuy A, Kerob D et al. Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients. J Am Acad Dermatol 2007 56 : 624 628.
75. Lee RA, Dommasch E, Treat J et al. A prospective clinical trial of open-label etanercept for the treatment of hidradenitis suppurativa. J Am Acad Dermatol 2009 60 : 565 573.
76. Brunasso AM, Delfino C, Massone C. Hidradenitis suppurativa: are tumour necrosis factor-alpha blockers the ultimate alternative? Br J Dermatol 2008 159 : 761 763.
77. Fröhlich D, Baaske D, Glatzel M. Radiotherapy of hidradenitis suppurativa - still valid today? Strahlenther Onkol 2000 176 : 286 289.
78. Lapins J, Emtestam L. Surgery. In : Jemec G, Revuz J. Leyden J, eds Hidradenitis suppurativa ' Vol. 1, Springer, 160 173.
79. Barron J. The surgical treatment of peri anal hidradenitis suppurativa. Dis Colon Rectum 1970 13 : 441 443.
80. Jemec GB. Effect of localized surgical excisions in hidradenitis suppurativa. J Am Acad Dermatol 1988 18 (Part 1 1103 1107.
81. Lapins J, Marcusson JA, Emtestam L. Surgical treatment of chronic hidradenitis suppurativa: CO2 laser stripping-secondary intention technique. Br J Dermatol 1994 131 : 551 556.
82. Lapins J, Sartorius K, Emtestam L. Scanner-assisted carbon dioxide laser surgery: a retrospective follow-up study of patients with hidradenitis suppurativa. J Am Acad Dermatol 2002 47 : 280 285.
83. O'Reilly DJ, Pleat JM, Richards AM. Treatment of hidradenitis suppurativa with botulinum toxin A. Plast Reconstr Surg 2005 116 : 1575 1576.
84. Strauss RM, Pollock B, Stables GI, Goulden V, Cunliffe WJ. Photodynamic therapy using aminolaevulinic acid does not lead to clinical improvement in hidradenitis suppurativa. Br J Dermatol 2005l 152 : 803 804.